Hence, Sophoridine decreased ETS‐1 expression to down‐regulate VEGFR2 expression along with downstream RAS/MEK/ERK axis in LR HCC cells, which explained the underlying mechanism responsible for increasing the sensitivity of LR HCC to lenvatinib treatment. The gene discussed is KDR; the disease is hepatocellular carcinoma.